Aurora Cannabis Inc (ACB.TO) saw its stock price drop by 4.13% in the last trading session, closing at CA$3.95.
This decline reflects ongoing concerns among investors, even though the company recently reported positive revenue figures. With a market cap of about CA$249.9 million, Aurora's performance raises questions about its future in the competitive cannabis market.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$227.95M
52W high
$9.33
52W low
$3.59
1W change
-3.42%
Beta
1.35
Analyst Price Targets
Based on analyst covering ACB
Wall Street analysts forecast ACB stock price to rise 59.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.84
+59.1% Upside
Current Price
C$3.67
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
37.1%
Annualized
90-Day Vol
48.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$3.07
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.46 | C$3.04 โ C$3.93 |
| 60 trading days | C$3.26 | C$2.72 โ C$3.90 |
| 90 trading days | C$3.07 | C$2.46 โ C$3.83 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious about Aurora Cannabis Inc's recent stock decline and consider the broader implications of its financial performance and market sentiment.
Aurora Cannabis Inc's stock drops 4.13% in one day.
Despite achieving record revenues, Aurora's stock price shows uncertainty in the cannabis market, with investors reacting to broader economic factors.
Bull case
Aurora recently announced record annual global medical cannabis net revenue of CA$288.6 million, which is an 18% increase from last year. This indicates strong demand in its sector.
Bear case
The stock's drop today highlights investor skepticism, likely due to concerns about profitability, as shown by a negative profit margin of -42.41%.
Market Reaction to Aurora's Performance
The 4.13% drop in Aurora's stock price comes despite the company announcing record annual revenues. Investors seem to be weighing these positive financial results against ongoing worries about profitability and market competition.
Understanding the Cannabis Market Landscape
Aurora operates in a highly competitive cannabis market, where stock price fluctuations can be influenced by broader economic factors and regulatory changes. Investors are encouraged to stay informed about market trends that could impact Aurora's performance.
Looking Ahead: Whatโs Next for ACB.TO?
As Aurora prepares for its upcoming investor conference call, stakeholders will be eager to hear insights on future strategies and how the company plans to navigate the challenges it faces in the cannabis industry.
Advertisement
